.

Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Boehringer Ingelheim
Fuji
Mallinckrodt
Argus Health
McKinsey
Harvard Business School
Chubb
Medtronic
Daiichi Sankyo

Generated: December 15, 2017

DrugPatentWatch Database Preview

Theophylline - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for theophylline and what is the scope of theophylline patent protection?

Theophylline
is the generic ingredient in fifty-two branded drugs marketed by Fleming Pharms, Forest Labs, Sanofi Aventis Us, Graham Dm, Actient Pharms, Auxilium Pharms Inc, Auxilium Pharms Llc, Schering, Whitby, Schwarz Pharma, Ortho Mcneil Pharm, Cent Pharms, Hospira, Inwood Labs, Sandoz, Scherer Rp, Fisons, Kv Pharm, Cenci, Lannett, Panray, Alpharma Us Pharms, Chartwell Rx, Halsey, Pharm Assoc, Precision Dose, Roxane, Taro, Wockhardt, B Braun, Baxter Hlthcare, Hospira Inc, Nostrum Labs Inc, 3M, Silarx, Tris Pharma Inc, Ferndale Labs, Warner Chilcott, Monarch Pharms, Roerig, Pharm Res Assoc, Nostrum Pharms Llc, Able, Alembic Pharms Ltd, Glenmark Generics, Mylan Ireland Ltd, Pliva, Rhodes Pharms, Teva Pharms, Medicis, and Novartis, and is included in one hundred and nineteen NDAs. Additional information is available in the individual branded drug profile pages.

There are thirty-six drug master file entries for theophylline. Thirty suppliers are listed for this compound.

Pharmacology for theophylline

Ingredient-typeXanthines
Drug ClassMethylxanthine
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Ortho Mcneil PharmTHEOPHYL-225theophyllineELIXIR;ORAL086485-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
CenciELIXOMINtheophyllineELIXIR;ORAL088303-001Jan 25, 1984DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
MedicisTHEOLAIRtheophyllineTABLET;ORAL086399-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
ScheringTHEO-DURtheophyllineTABLET, EXTENDED RELEASE;ORAL085328-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Forest LabsDURAPHYLtheophyllineTABLET, EXTENDED RELEASE;ORAL088505-001Apr 3, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Forest LabsDURAPHYLtheophyllineTABLET, EXTENDED RELEASE;ORAL088503-001Apr 3, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Sanofi Aventis UsSLO-PHYLLINtheophyllineCAPSULE, EXTENDED RELEASE;ORAL085203-001May 24, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Scherer RpTHEOPHYLLINEtheophyllineCAPSULE;ORAL084731-002Nov 7, 1986DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Graham DmSOMOPHYLLIN-CRTtheophyllineCAPSULE, EXTENDED RELEASE;ORAL087763-001Feb 27, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
TaroTHEOPHYLLINEtheophyllineELIXIR;ORAL089626-001Oct 28, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: theophylline

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Monarch PharmsQUIBRON-T/SRtheophyllineTABLET, EXTENDED RELEASE;ORAL087563-001Jun 21, 1983► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

UBS
Citi
US Department of Justice
Moodys
McKesson
Deloitte
Baxter
Federal Trade Commission
US Army
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot